I agree both drugs have potential I just happen to be invested in humanigen, I have looked at and traded cydy, made money on it. I am impressed with the amount of retail support you have, my main reservation is the leader, i have checked him out and I don’t think it is unfair to say he does not have essentially any experience with a new drug roll out .
My thought is having experience in this is critical in avoiding pitfalls and mistakes and redos. Maybe I’m wrong ..Lifelong connections do make it much easier to get someone to pick up the phone.
I know there is a lively debate over there regarding this topic and that there are some ardent supporters of him as well.
Other than that I do agree with with the premise that
There is certainly room for several players in this area.
The reason I like HGEN is more than science,
The management appears to be first rate , the financial backing world class, the share disposition is superior.
So to me it’s not even close as to who is in a better position at this time
That said absolutely anything can and probably will happen
Thanks for being rational in the debate by the way , I have taken quite an interest in the CYDY board , you have some rather ardent defenders wanting to pick fights over here lol. “Can’t we all get along”
All I can say is
GLTA